For example, partial responses have been induced by autologous transfer of ex vivo activated antigen presenting cells [5]–[6], cytokine-secreting tumor vaccines [7], vaccines containing recombinant proteins or nucleic acids and other cell-based strategies targeting cancer antigens, such as PSA or prostate-specific membrane antigen [8]. The gene discussed is KLK3; the disease is cancer.